Ratings PT Siloam International Hospitals Tbk

Equities

SILO

ID1000129208

End-of-day quote INDONESIA S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
2,290 ^IDR	-10.20%		-11.58%	+5.05%

Mar. 25	PT Siloam International Hospitals Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	PT Siloam International Hospitals Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
The company is in a robust financial situation considering its net cash and margin position.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For several months, analysts have been revising their EPS estimates roughly upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
The opinion of analysts covering the stock has improved over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is not the most generous with respect to shareholders' compensation.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	ESG Refinitiv
PT SILOAM INTERNATIONAL HOSPITALS TBK	+5.05%	1.83B	-
AIER EYE HOSPITAL GROUP CO., LTD.	-20.16%	16.21B	B+
BANGKOK DUSIT MEDICAL SERVICES	+4.50%	12.44B	B
IHH HEALTHCARE	+3.98%	11.58B	B+
APOLLO HOSPITALS ENTERPRISE LIMITED	+9.72%	10.79B	B+
RAMSAY HEALTH CARE LIMITED	-2.19%	7.68B	A-
MOUWASAT MEDICAL SERVICES COMPANY	+18.43%	7.2B	D
THE ENSIGN GROUP, INC.	+4.49%	6.67B	B-
GLOBAL HEALTH LIMITED	+50.89%	4.66B	-
DALLAH HEALTHCARE COMPANY	-5.12%	4.25B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes